-
1
-
-
11944274532
-
The influence of age and sex on the clearance of cytochrome P450 3A substrates
-
10.2165/00003088-200544010-00002 1:CAS:528:DC%2BD2MXhsVeisLY%3D 15634031
-
MM Cotreau LL von Moltke DJ Greenblatt 2005 The influence of age and sex on the clearance of cytochrome P450 3A substrates Clin Pharmacokinet 44 33 60 10.2165/00003088-200544010-00002 1:CAS:528:DC%2BD2MXhsVeisLY%3D 15634031
-
(2005)
Clin Pharmacokinet
, vol.44
, pp. 33-60
-
-
Cotreau, M.M.1
Von Moltke, L.L.2
Greenblatt, D.J.3
-
2
-
-
54049096401
-
Gender has a small but statistically significant effect on clearance of CYP3A substrate drugs
-
10.1177/0091270008323754 1:CAS:528:DC%2BD1cXhtlyrs7bE 18757784
-
DJ Greenblatt LL von Moltke 2008 Gender has a small but statistically significant effect on clearance of CYP3A substrate drugs J Clin Pharmacol 48 1350 1355 10.1177/0091270008323754 1:CAS:528:DC%2BD1cXhtlyrs7bE 18757784
-
(2008)
J Clin Pharmacol
, vol.48
, pp. 1350-1355
-
-
Greenblatt, D.J.1
Von Moltke, L.L.2
-
3
-
-
66749088074
-
Sex differences of drug-metabolizing enzyme: Female predominant expression of human and mouse cytochrome P450 3A isoforms
-
10.1248/jhs.55.325
-
T Sakuma Y Kawasaki K Jarukamjorn N Nemoto 2009 Sex differences of drug-metabolizing enzyme: female predominant expression of human and mouse cytochrome P450 3A isoforms J Health Sci 55 328 337 10.1248/jhs.55.325
-
(2009)
J Health Sci
, vol.55
, pp. 328-337
-
-
Sakuma, T.1
Kawasaki, Y.2
Jarukamjorn, K.3
Nemoto, N.4
-
4
-
-
65349137639
-
Sex differences in pharmacokinetics and pharmacodynamics
-
10.2165/00003088-200948030-00001 1:CAS:528:DC%2BD1MXmtlant7g%3D 19385708
-
OP Soldin DR Mattison 2009 Sex differences in pharmacokinetics and pharmacodynamics Clin Pharmacokinet 48 143 157 10.2165/00003088-200948030-00001 1:CAS:528:DC%2BD1MXmtlant7g%3D 19385708
-
(2009)
Clin Pharmacokinet
, vol.48
, pp. 143-157
-
-
Soldin, O.P.1
Mattison, D.R.2
-
5
-
-
73449141860
-
Gender and interindividual variability in pharmacokinetics
-
10.1080/10837450902891485 1:CAS:528:DC%2BD1MXosV2mtL4%3D 19601720
-
J Nicolas P Espie M Molimard 2009 Gender and interindividual variability in pharmacokinetics Drug Metab Rev 41 408 421 10.1080/10837450902891485 1:CAS:528:DC%2BD1MXosV2mtL4%3D 19601720
-
(2009)
Drug Metab Rev
, vol.41
, pp. 408-421
-
-
Nicolas, J.1
Espie, P.2
Molimard, M.3
-
6
-
-
1342302371
-
Sex differences in pharmacokinetics and pharmacodynamics
-
10.1146/annurev.pharmtox.44.101802.121453 1:CAS:528:DC%2BD2cXhvVCktb8%3D 14744256
-
M Gandhi F Aweeka RM Greenblatt TF Blaschke 2004 Sex differences in pharmacokinetics and pharmacodynamics Annu Rev Pharmacol Toxicol 44 499 523 10.1146/annurev.pharmtox.44.101802.121453 1:CAS:528:DC%2BD2cXhvVCktb8%3D 14744256
-
(2004)
Annu Rev Pharmacol Toxicol
, vol.44
, pp. 499-523
-
-
Gandhi, M.1
Aweeka, F.2
Greenblatt, R.M.3
Blaschke, T.F.4
-
7
-
-
0037275143
-
The influence of sex on pharmacokinetics
-
10.2165/00003088-200342020-00001 1:CAS:528:DC%2BD3sXhsFyntbs%3D 12537512
-
JB Schwartz 2003 The influence of sex on pharmacokinetics Clin Pharmacokinet 42 107 121 10.2165/00003088-200342020-00001 1:CAS:528: DC%2BD3sXhsFyntbs%3D 12537512
-
(2003)
Clin Pharmacokinet
, vol.42
, pp. 107-121
-
-
Schwartz, J.B.1
-
9
-
-
0042916560
-
Pharmacokinetic properties of zolpidem in elderly and young adults: Possible modulation by testosterone
-
10.1046/j.0306-5251.2003.01852.x 1:CAS:528:DC%2BD3sXnvVSguro%3D 12919178
-
JO Olubodun HR Ochs LL von Moltke R Roubenoff LM Hesse JS Harmatz RI Shader DJ Greenblatt 2003 Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone Br J Clin Pharmacol 56 297 304 10.1046/j.0306-5251.2003.01852.x 1:CAS:528:DC%2BD3sXnvVSguro%3D 12919178
-
(2003)
Br J Clin Pharmacol
, vol.56
, pp. 297-304
-
-
Olubodun, J.O.1
Ochs, H.R.2
Von Moltke, L.L.3
Roubenoff, R.4
Hesse, L.M.5
Harmatz, J.S.6
Shader, R.I.7
Greenblatt, D.J.8
-
10
-
-
0029074925
-
Clinical pharmacokinetics and pharmacodynamics of zolpidem: Therapeutic implications
-
10.2165/00003088-199529030-00002 8521677
-
P Salvà J Costa 1995 Clinical pharmacokinetics and pharmacodynamics of zolpidem: therapeutic implications Clin Pharmacokinet 29 142 153 10.2165/00003088-199529030-00002 8521677
-
(1995)
Clin Pharmacokinet
, vol.29
, pp. 142-153
-
-
Salvà, P.1
Costa, J.2
-
11
-
-
1842866515
-
Quinidine and haloperidol as modifiers of CYP3A4 activity: Multisite kinetic model approach
-
10.1124/dmd.30.12.1512 1:CAS:528:DC%2BD38XptVyisbY%3D 12433827
-
A Galetin SE Clarke JB Houston 2002 Quinidine and haloperidol as modifiers of CYP3A4 activity: multisite kinetic model approach Drug Metab Dispos 30 1512 1522 10.1124/dmd.30.12.1512 1:CAS:528:DC%2BD38XptVyisbY%3D 12433827
-
(2002)
Drug Metab Dispos
, vol.30
, pp. 1512-1522
-
-
Galetin, A.1
Clarke, S.E.2
Houston, J.B.3
-
12
-
-
0042357511
-
Multisite kinetic analysis of interactions between prototypical CYP3A4 subgroup substrates: Midazolam, testosterone, and nifedipine
-
10.1124/dmd.31.9.1108 1:CAS:528:DC%2BD3sXmslKlurY%3D 12920166
-
A Galetin SE Clarke JB Houston 2003 Multisite kinetic analysis of interactions between prototypical CYP3A4 subgroup substrates: midazolam, testosterone, and nifedipine Drug Metab Dispos 31 1108 1116 10.1124/dmd.31.9. 1108 1:CAS:528:DC%2BD3sXmslKlurY%3D 12920166
-
(2003)
Drug Metab Dispos
, vol.31
, pp. 1108-1116
-
-
Galetin, A.1
Clarke, S.E.2
Houston, J.B.3
-
13
-
-
0032735988
-
CYP3A4 drug interactions: Correlation of 10 in vitro probe substrates
-
10.1046/j.1365-2125.1999.00073.x 1:CAS:528:DyaK1MXnvFSrtr8%3D 10594474
-
KE Kenworthy JC Bloomer SE Clarke JB Houston 1999 CYP3A4 drug interactions: correlation of 10 in vitro probe substrates Br J Clin Pharmacol 48 716 727 10.1046/j.1365-2125.1999.00073.x 1:CAS:528:DyaK1MXnvFSrtr8%3D 10594474
-
(1999)
Br J Clin Pharmacol
, vol.48
, pp. 716-727
-
-
Kenworthy, K.E.1
Bloomer, J.C.2
Clarke, S.E.3
Houston, J.B.4
-
14
-
-
0035193493
-
Multisite kinetic models for CYP3A4: Simultaneous activation and inhibition of diazepam and testosterone metabolism
-
1:CAS:528:DC%2BD3MXovFKrtL4%3D 11717184
-
KE Kenworthy SE Clarke J Andrews JB Houston 2001 Multisite kinetic models for CYP3A4: simultaneous activation and inhibition of diazepam and testosterone metabolism Drug Metab Dispos 29 1644 1651 1:CAS:528:DC%2BD3MXovFKrtL4%3D 11717184
-
(2001)
Drug Metab Dispos
, vol.29
, pp. 1644-1651
-
-
Kenworthy, K.E.1
Clarke, S.E.2
Andrews, J.3
Houston, J.B.4
-
15
-
-
0034093628
-
Human cytochrome P-450 3A4: In vitro drug-drug interaction patterns are substrate-dependent
-
1:CAS:528:DC%2BD3cXhsVOit78%3D 10681383
-
RW Wang DJ Newton N Liu WM Atkins AY Lu 2000 Human cytochrome P-450 3A4: in vitro drug-drug interaction patterns are substrate-dependent Drug Metab Dispos 28 360 366 1:CAS:528:DC%2BD3cXhsVOit78%3D 10681383
-
(2000)
Drug Metab Dispos
, vol.28
, pp. 360-366
-
-
Wang, R.W.1
Newton, D.J.2
Liu, N.3
Atkins, W.M.4
Lu, A.Y.5
-
16
-
-
77956183952
-
Zolpidem pharmacokinetics and pharmacodynamics in metabolic interactions involving CYP3A: Sex as differentiating factor
-
in press
-
Cubala WJ, Wiglusz M, Burkiewicz A, Galuszko-Wegielnil M (2010) Zolpidem pharmacokinetics and pharmacodynamics in metabolic interactions involving CYP3A: sex as differentiating factor. Eur J Clin Pharmacol; in press
-
(2010)
Eur J Clin Pharmacol
-
-
Cubala, W.J.1
Wiglusz, M.2
Burkiewicz, A.3
Galuszko-Wegielnil, M.4
-
17
-
-
77951916870
-
In vitro-in vivo extrapolation of zolpidem as a perpetrator of metabolic interactions involving CYP3A
-
10.1007/s00228-009-0760-2 1:CAS:528:DC%2BC3cXitVOgsbw%3D 20012430
-
TM Polasek JS Sadagopal DJ Elliot JO Miners 2010 In vitro-in vivo extrapolation of zolpidem as a perpetrator of metabolic interactions involving CYP3A Eur J Clin Pharmacol 66 275 283 10.1007/s00228-009-0760-2 1:CAS:528:DC%2BC3cXitVOgsbw%3D 20012430
-
(2010)
Eur J Clin Pharmacol
, vol.66
, pp. 275-283
-
-
Polasek, T.M.1
Sadagopal, J.S.2
Elliot, D.J.3
Miners, J.O.4
-
18
-
-
39849099803
-
Zolpidem abuse, dependence and withdrawal syndrome: Sex as susceptibility factor for adverse effects
-
10.1111/j.1365-2125.2007.03028.x 17875189
-
WJ Cubala J Landowski HM Wichowicz 2008 Zolpidem abuse, dependence and withdrawal syndrome: sex as susceptibility factor for adverse effects Br J Clin Pharmacol 65 444 445 10.1111/j.1365-2125.2007.03028.x 17875189
-
(2008)
Br J Clin Pharmacol
, vol.65
, pp. 444-445
-
-
Cubala, W.J.1
Landowski, J.2
Wichowicz, H.M.3
-
19
-
-
33846449874
-
Mechanism-based inactivation of human cytochrome P450 enzymes and the prediction of drug-drug interactions
-
10.1124/dmd.106.012633 1:CAS:528:DC%2BD2sXhvVKrs7k%3D 17093004
-
RS Obach RL Walsky K Venkatakrishnan 2007 Mechanism-based inactivation of human cytochrome P450 enzymes and the prediction of drug-drug interactions Drug Metab Dispos 35 246 255 10.1124/dmd.106.012633 1:CAS:528:DC%2BD2sXhvVKrs7k%3D 17093004
-
(2007)
Drug Metab Dispos
, vol.35
, pp. 246-255
-
-
Obach, R.S.1
Walsky, R.L.2
Venkatakrishnan, K.3
-
20
-
-
77549084821
-
Physiologically based mechanistic modelling to predict complex drug-drug interactions involving simultaneous competitive and time-dependent enzyme inhibition by parent compound and its metabolite in both liver and gut-The effect of diltiazem on the time-course of exposure to triazolam
-
10.1016/j.ejps.2009.12.002 1:CAS:528:DC%2BC3cXjtVWksbs%3D 20025966
-
K Rowland Yeo M Jamei J Yang GT Tucker A Rostami-Hodjegan 2010 Physiologically based mechanistic modelling to predict complex drug-drug interactions involving simultaneous competitive and time-dependent enzyme inhibition by parent compound and its metabolite in both liver and gut-the effect of diltiazem on the time-course of exposure to triazolam Eur J Pharm Sci 39 298 309 10.1016/j.ejps.2009.12.002 1:CAS:528:DC%2BC3cXjtVWksbs%3D 20025966
-
(2010)
Eur J Pharm Sci
, vol.39
, pp. 298-309
-
-
Rowland Yeo, K.1
Jamei, M.2
Yang, J.3
Tucker, G.T.4
Rostami-Hodjegan, A.5
-
21
-
-
34548283499
-
In vitro approaches to investigate mechanism-based inactivation of CYP enzymes
-
10.1517/17425255.3.3.321 1:CAS:528:DC%2BD2sXlvFaktrY%3D 17539741
-
TM Polasek JO Miners 2007 In vitro approaches to investigate mechanism-based inactivation of CYP enzymes Expert Opin Drug Metab Toxicol 3 321 329 10.1517/17425255.3.3.321 1:CAS:528:DC%2BD2sXlvFaktrY%3D 17539741
-
(2007)
Expert Opin Drug Metab Toxicol
, vol.3
, pp. 321-329
-
-
Polasek, T.M.1
Miners, J.O.2
|